Stock listing
GH Stock Price, News, Filings & Events — Guardant Health, Inc.
Selected listing: GH · NASDAQ · USD · US
This page tracks Guardant Health, Inc.'s GH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:NASDAQ. GH:NASDAQ is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.

- Ticker
- GH:NASDAQ
- Asset type
- Stock
- Market cap
- $19.54B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Guardant Health, Inc. GH:NASDAQ stock context
This page tracks Guardant Health, Inc.'s GH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GH:NASDAQ. GH:NASDAQ is the stock-level entry point for investors researching Guardant Health, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Guardant Health, Inc. is a publicly traded company listed under the ticker GH, operating in the American market. The company has a market capitalization of approximately $19.54 billion. Guardant Health specializes in advanced genomic testing for cancer, focusing on non-invasive blood tests to help guide treatment decisions.
Research Guardant Health, Inc.
Guardant Health, Inc. investor report
Review AI stock analysis and investor report context for GH:NASDAQ.
Guardant Health, Inc. company profile
View the public company page for Guardant Health, Inc. on 6ix.
Guardant Health, Inc. news
Read company news and market updates connected to Guardant Health, Inc..
Guardant Health, Inc. investor events
Find investor webinars, events, and replay context for Guardant Health, Inc..
Alternate listings
5GH:GETTEX
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
A2N5RY:LSX
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
A2N5RY:LS
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
5GH:TRADEGATE
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
GH:BX
CH · CHF
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
GH:BMV
MX · MXN
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
GH:BIVA
MX · MXN
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
GH:BOATS
US · USD
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
1GH:MIL
IT · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
5GH:FWB
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
5GH:MUN
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.
5GH:DUS
DE · EUR
Alternate listing for Guardant Health, Inc.; the primary context on this page is GH:NASDAQ.